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Abstract
GABA (gamma-aminobutyric-acid), the main inhibitory neurotransmitter in the adult brain, exerts depolarizing (excitatory)
actions during development and this GABAergic depolarization cooperates with NMDARs (N-methyl-D-aspartate receptors)
to drive spontaneous synchronous activity (SSA) that is fundamentally important for developing neuronal networks.
Although GABAergic depolarization is known to assist in the activation of NMDARs during development, the subcellular
localization of NMDARs relative to GABAergic synapses is still unknown. Here, we investigated the subcellular distribution of
NMDARs in association with GABAergic synapses at the developmental stage when SSA is most prominent in mice. Using
multiple immunofluorescent labeling and confocal laser-scanning microscopy in the developing mouse hippocampus, we
found that NMDARs were associated with both glutamatergic and GABAergic synapses at postnatal day 6–7 and we
observed a direct colocalization of GABAA- and NMDA-receptor labeling in GABAergic synapses. Electron microscopy of pre-
embedding immunogold-immunoperoxidase reactions confirmed that GluN1, GluN2A and GluN2B NMDAR subunits were
all expressed in glutamatergic and GABAergic synapses postsynaptically. Finally, quantitative post-embedding immunogold
labeling revealed that the density of NMDARs was 3 times higher in glutamatergic than in GABAergic synapses. Since
GABAergic synapses were larger, there was little difference in the total number of NMDA receptors in the two types of
synapses. In addition, receptor density in synapses was substantially higher than extrasynaptically. These data can provide
the neuroanatomical basis of a new interpretation of previous physiological data regarding the GABAAR-NMDAR
cooperation during early development. We suggest that during SSA, synaptic GABAAR-mediated depolarization assists
NMDAR activation right inside GABAergic synapses and this effective spatial cooperation of receptors and local change of
membrane potential will reach developing glutamatergic synapses with a higher probability and efficiency even further
away on the dendrites. This additional level of cooperation that operates within the depolarizing GABAergic synapse, may
also allow its own modification triggered by Ca2+-influx through the NMDA receptors.
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Introduction
Spontaneous synchronous activity (SSA) – also known as giant
depolarizing potential/GDP in vitro, or developmental sharp wave
in vivo [1] – is a fundamental feature of developing networks, it is
conserved through evolution, and can be observed throughout the
entire central nervous system [2]. Synaptic transmission and this
correlated synchronous activity of neuronal ensembles are
fundamental for proper circuit formation in the developing brain
[2,3]. This is achieved by the depolarizing actions of GABAA-
receptors and activation of N-methyl-D-aspartate ionotropic
glutamate receptors (NMDARs) during early postnatal days [4,5].
NMDARs are essential contributors to fast glutamatergic
excitatory synaptic transmission, as well as to several forms of
synaptic plasticity in the adult brain; however, they also play
critical roles during the development of neuronal networks.
Blockade of NMDARs at this age greatly reduces synchronous
network activity both in neocortex and in hippocampus [6–8], and
leads to a series of severe neuromorphological and behavioral
deficits [9–12]. Furthermore, NMDAR activation is also essential
for the recruitment of AMPA (2-amino-3-(5-methyl-3-oxo-1,2-
oxazol-4-yl)propionic acid) receptors into silent synapses and for
other types of Ca2+-dependent synaptic plasticity during de-
velopment [13–16].
The contribution of GABAARs and NMDARs to the first
synapse-driven synchronous activities is essential [4,5]. Previous
findings also showed that after the recruitment of AMPA receptors
to glutamatergic synapses, AMPA receptors may also contribute to
the SSA, but their blockade has little influence on it [4,6,17]. In
the first postnatal week, GABA exerts a complex depolarizing
(excitatory/shunting inhibitory) action [18], and this GABAergic
depolarization is sufficient – even in the absence of functional
AMPA receptors - to remove the Mg2+-block from the NMDARs,
thus leading to a postsynaptic calcium influx that is required for
the developmentally relevant synchronous network activity, and
the recruitment of AMPA receptors into silent synapses. Pre-
viously, NMDARs responsible for the GABAAR-NMDAR co-
operation were thought to be present exclusively in glutamatergic
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synapses [19]. However, several studies concluded that the
emergence of GABAergic synapses precedes that of glutamatergic
ones [20–22], therefore it is not clear whether NMDARs at those
glutamatergic synapses could be the only NMDARs that are
responsible for the massive GABAAR-NMDAR cooperation
during early SSAs. Previous physiological studies did not in-
vestigate whether these NMDAR currents originated from
glutamatergic synapses or from other NMDARs closer to
GABAergic synapses. This question is even more prominent in
the light of our previous work, in which we proved the presence of
NMDARs in GABAergic synapses of the adult brain [23].
NMDAR expression has been extensively studied in the adult
brain, and there is substantial knowledge concerning their
presence during development. The low-resolution distribution of
different NMDAR subunit mRNAs and proteins has been
described [24–26], and ultrastructural studies proved the presence
of NMDAR subunits both synaptically and extrasynaptically
[19,27]. However, in spite of their obvious importance, the precise
subcellular distribution of NMDAR subunits during postnatal
development is unknown. In this study, we examined the exact
membrane distribution of NMDARs at an age, when the first
synapse-driven synchronous network activity is maximal (at
postnatal day 6–7, P6-7) [6,7] and GABAergic synapses are still
depolarizing. Using confocal laser-scanning microscopy, we
showed that NMDARs were associated with glutamatergic and
GABAergic synapses and we could observe direct colocalization of
GABAA and NMDA receptors in GABAergic synapses. Our
electron-microscopic results confirmed that GluN1, GluN2A and
GluN2B subunits (formerly known as NR1, NR2A and NR2B
subunits, respectively) were all expressed postsynaptically in both
glutamatergic and GABAergic synapses at P6-7. Quantitative
analysis of high-resolution post-embedding immunogold reactions
revealed that the density of NMDARs in glutamatergic synapses
was 3 times higher than in GABAergic synapses, and that
extrasynaptic membranes expressed these receptors with a density
almost two orders of magnitude lower than synapses do. Since
GABAergic synapses were about two times larger than glutama-
tergic ones, there is little difference in the total number of
NMDARs in the two types of synapses at this age. Our findings
could provide the neuroanatomical basis of a new interpretation of
previous physiological data. Here we hypothesize that, during
early development, NMDA receptors are essential in developing
GABAergic synapses for Ca2+-dependent synaptic plasticity, for
a sufficiently strong local depolarization to assist the maturation of
distant glutamatergic synapses, as well as for driving SSAs.
Results
Confocal Microscopy Reveals an Association of NMDARs
with Both Glutamatergic and GABAergic Synapses during
Development
NMDARs have heterotetrameric structure with two GluN1
subunits and usually with two GluN2 subunits [28]. Since the
GluN1 subunit is obligatory for functional NMDARs [29], to
localize these receptors, we performed immunofluorescent labeling
experiments with antibodies against this subunit. Synapses were
labeled with an antibody against Bassoon, a presynaptic active
zone protein. Glutamatergic and GABAergic terminals were
labeled with anti-type 1 vesicular glutamate transporter (vGluT1)
and an anti-glutamate decarboxylase 65/67 (GAD65/67) anti-
body, respectively. The overall staining pattern in different
hippocampal layers of the CA1 area can be seen in Fig. 1A.
During development, numerous glutamatergic and GABAergic
synapses are present in stratum radiatum of the hippocampal CA1
region, therefore we investigated this area. vGluT1 and GAD65/
67 staining appeared as a non-overlapping punctate labeling
pattern, showing the distribution of glutamatergic and GABAergic
synapses, respectively. In the quadruple-labeling experiments, we
found that Bassoon-positive patches were associated to either
vGluT1 or GAD65/67 positive terminals. In several cases, GluN1
subunit labeling was found to be associated to the Bassoon-labeled
synapses of both vGluT1-positive (glutamatergic) and GAD65/67-
positive (GABAergic) terminals at P6-7 (Fig. 1B; n = 4 animals).
Furthermore, we used confocal laser-scanning microscopy to
show direct colocalization of GABAA- and NMDA-receptors
within the same synapses. First, we used a triple labeling protocol
for Bassoon, GluN1, and GABAAR beta3 subunit (Fig. 1C, n = 2
animals), and in some cases we observed that labeling for GluN1
and GABAAR beta3 subunits overlapped, and were juxtaposed to
Bassoon-positive patches. Second, we used double-labeling against
the extracellular loop of the GluN1 subunit, combined with
GABAAR gamma2 subunit (Fig. 1D, n = 2 animals) and we also
found a frequent association of the GluN1 subunit with GABAAR
gamma2 labeling. Although the specificity of this method is high,
due to its moderate sensitivity, quantification was not performed.
Our results obtained using these fluorescent staining experiments
suggested that GluN1 labeling associated with GABAAR-positive
puncta, which showed the synaptic co-expression of NMDARs
and GABAARs during postnatal development. Although these
data suggested a close association of NMDARs to both types of
synapses, these receptors could still be either pre- or postsynaptic,
as well as peri- or intrasynaptic. Therefore, to obtain data that are
more precise, we performed electron microscopic experiments as
well.
Preembedding Immunogold Electron Microscopy
Confirms the Presence of Three Types of NMDAR
Subunits Postsynaptically in Glutamatergic and
GABAergic Synapses during Development
Since the GABAAR and NMDAR dependent synchronous
network activity is most prominent around P6-7 in mice [6,7], we
focused our experiments on this developmental stage. We
performed immunogold-immunoperoxidase reactions in several
combinations. GluN1, GluN2B or GluN2A subunits were labeled
with immunogold particles, while glutamatergic and GABAergic
terminals were labeled for vGluT1 or GAD67 with the peroxidase
method, respectively. Randomly sampled synapses from the
stratum radiatum of the CA1 area were examined in each
reaction. We found that all three tested subunits of NMDARs were
present postsynaptically in both glutamatergic and GABAergic
synapses at P6-7 (Fig. 2). Synapses were fully reconstructed from
serial electron-microscopic sections from two mice, and at least
51616% of all glutamatergic (n = 41) and 53613% of all
GABAergic synapses (n = 40) were found to be positive for the
GluN1 subunit (Fig. 2A and 2B, Fig. 3A). The linear density of
immunolabeling was 1.9360.03 gold particles/mm in glutamater-
gic and 0.8760.29 gold particles/mm in GABAergic synapses, and
only 0.0960.01 gold particles/mm extrasynaptically, on 100 nm
thick sections (Fig. 3B, for details on measuring density of
immunogold particles, see Materials and Methods). Our data
showed that at least 8363% of all glutamatergic (n = 40) and
63613% of all GABAergic synapses (n = 40) were positive for the
GluN2B subunit (Fig. 2C and 2D1–D2, Fig. 3A). The linear
density of labeling was 3.1661.01 gold particles/mm in glutama-
tergic and 1.3860.34 gold particles/mm in GABAergic synapses,
and only 0.0360.01 gold particles/mm were found extrasynapti-
cally (Fig. 3B). At least 8868% of all glutamatergic (n = 40) and
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4961% of all GABAergic synapses (n = 43) contained GluN2A
subunits (Fig. 2E1–E2, 2F1–F3, Fig. 3A). The linear density of the
labeling was 3.4060.81 gold particles/mm in glutamatergic and
0.5960.28 gold particles/mm in GABAergic synapses, and only
0.0260.003 gold particles/mm were extrasynaptic (Fig. 3B).
Quantitative Postembedding Immunogold Method
Reveals Only Small Differences in the Number of
NMDARs in Glutamatergic and GABAergic Synapses
during Development
Because of technical limitations, the results of pre-embedding
experiments are only semi-quantitative; therefore, we performed
post-embedding immunogold labeling to obtain more precise
quantitative data on the subcellular distribution of NMDARs.
GluN1 staining represents well the distribution of NMDARs,
because GluN2 subunits are not transported to the cell-membrane
without GluN1 subunits [29], therefore GluN1 is present in all
NMDARs. We employed the so-called mirror technique to
measure the density of immunogold labeling for the GluN1
subunit. This method enabled us to count these immunogold
particles over synapses on the very same sections from two mice
and to identify GABAergic and glutamatergic synapses on the
mirror sections (for a detailed description, see Materials and
Methods). Using this method we could quantitatively compare
receptor expression of synaptic and extrasynaptic areas in the P6-7
mice. We randomly collected identified glutamatergic and
GABAergic synapses from the stratum radiatum of the CA1 area.
NMDAR labeling was detected in both glutamatergic (Fig. 4A–B)
and GABAergic synapses (Fig. 4C–D). Our measurements showed
that the labeling density was 2.4660.71 gold particles/mm in
Figure 1. NMDARs are associated with GABAergic and glutamatergic synapses during postnatal development. A, Maximal intensity
projection images of three image planes from deconvolved stacks show the general labeling patterns for each staining throughout the strata oriens
(ori.), pyramidale (pyr.) and radiatum (rad.) in the CA1 area of the hippocampus. B–D, Deconvolved confocal laser-scanning images of quadruple (B),
triple (C) and double (D) fluorescent labeling reactions from stratum radiatum of the hippocampal CA1 region. B, In quadruple labelings, vGluT1
(blue) labels glutamatergic axon terminals, GAD65/67 (white) labels GABAergic axon terminals, Bassoon (red) labels presynaptic active zones of both
types of synapses. GluN1 (green) is an obligatory NMDAR subunit and it is associated with both types of synapses at P6-7. GABAergic and
glutamatergic terminals were sampled from the same image stacks. C, In the triple reaction, Bassoon (red) labels presynaptic active zones, while the
labeling of GABAAR beta3 subunit (blue) and the obligatory NMDAR subunit GluN1 (green) is overlapping. D, In the double reaction, GABAAR
gamma2 subunit labeling (green) and the reaction against the extracellular loop of the GluN1 subunit (red) is overlapping as well. The images shown
on B, C and D are collected from the stratum radiatum of CA1 area, from single focal planes and the resolution of the imaging was
50 nm50 nm6150 nm/x-y-z voxel size. Scale bar is 50 mm for A, 500 nm for B and 350 nm for C and D.
doi:10.1371/journal.pone.0037753.g001
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glutamatergic (n = 32) and 0.8160.16 gold particles/mm in
GABAergic synapses (n = 28), and only 0.0360.01 gold parti-
cles/mm extrasynaptically (along 103 mm extrasynaptic membrane
segment, Fig. 3D). In order to establish the ratio of the absolute
number of NMDARs in glutamatergic versus GABAergic
synapses, we measured the synaptic areas and multiplied them
by the labeling densities measured above in the two types of
synapses. For the reliable estimation of synaptic areas, we
performed single preembedding immunoperoxidase reactions (on
strongly fixed tissue) with antisera against either vGluT1 or
GAD67 in two animals, and samples were embedded in Durcupan
resin. All synapses were sampled from stratum radiatum. The
glutamatergic synaptic area (n = 29) was found to be
0.09760.013 mm2, and GABAergic synapses (n = 32) were
0.18660.026 mm2 (Fig. 3C), i.e. the latter being 1.91 times larger
than the former. From these data we calculated that fully
reconstructed glutamatergic synapses would have been labeled
with 3.25 immunogold particles, while GABAergic synapses with
2.13 immunogold particles labeling NMDARs, which led to the
unexpected conclusion that glutamatergic synapses contain only
1.6 times more NMDARs than GABAergic synapses.
Preembedding results clearly showed a purely postsynaptic
localization of NMDARs in these synapses, nevertheless, we
confirmed this also by measuring the distance of NMDAR
immunogold labeling from the postsynaptic membrane. The
distance distribution of gold particles measured perpendicularly
Figure 2. NMDAR subunits are expressed postsynaptically in both GABAergic and glutamatergic synapses at postnatal day 6–7.
Electron micrographs show combined immunogold-immunoperoxidase reactions from stratum radiatum of the hippocampal CA1 region. Synapses
of vGluT1 positive presynaptic terminals (marked by dark reaction product in A, C, E1 and E2) contain postsynaptic GluN1 (black particles in A,
arrows), GluN2B (black particles in C, arrows), and GluN2A subunits (black particles in E1 and E2, arrows). Synapses of GAD67-positive presynaptic
terminals (marked by dark reaction product in B, D1, D2, F1, F2 and F3) contain postsynaptic GluN1 (black particles in B, arrows), GluN2B (black
particles in D1 and D2, arrows), and GluN2A subunits (black particles on F1, F2 and F3, arrows). Serial images show the same synapse in D1 and D2; E1
and E2; F1, F2 and F3. Scale bar is 300 nm for all images.
doi:10.1371/journal.pone.0037753.g002
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from the postsynaptic membrane was very similar in GABAergic
(median: 3.63 nm, interquartile range: 28.12–13.78 nm, n = 28)
and glutamatergic synapses (median 7.26 nm, interquartile range
27.87–13.49 nm, n = 32, positive values refer to intracellular
positions), confirming the postsynaptic origin of the immunogold
labeling.
Discussion
Here we investigated the subcellular distribution of NMDARs
in the mouse hippocampus at the age, when GABA exerts
depolarizing effects and the first synapse-driven synchronous
network activity emerges (P6-7). Our major findings are that 1)
NMDARs are associated with glutamatergic as well as GABAergic
synapses, 2) GluN1, GluN2A and GluN2B subunits are all
expressed postsynaptically in both glutamatergic and GABAergic
synapses, 3) the density of NMDARs in glutamatergic synapses is
about 3 times higher than in GABAergic synapses, and about 90
times higher than extrasynaptically and 4) since GABAergic
synapses are larger, there is little difference in the NMDA receptor
content of the two types of synapses at this age.
Co-expression of GABAA- and NMDA-receptors in GABAergic
synapses during the first synapse-driven synchronous network
events provide neuroanatomical evidence that the substrate of
GABAAR-NMDAR cooperation in developing synapses could
well be the GABAergic synapse. According to this model,
GABAARs may facilitate the activation of NMDARs inside the
same developing GABAergic synapse, the combined effect of
which could be sufficient to depolarize even distant silent (only
NMDAR-containing) glutamatergic synapses, and thereby allow-
ing them to recruit AMPA receptors.
NMDARs in Developmental Synchronous Network
Activity
Spontaneous synchronous activity (SSA) is a fundamental
feature of developing networks and indispensable for the formation
and refinement of synapses [13,30]. It is evolutionarily conserved,
was shown to be present in primates including the human brain
[21,31], and can be observed throughout the mammalian central
nervous system [2]. SSA-s are primarily dependent on synaptic
transmission, the depolarizing actions of GABAergic transmission
[32,33], and the activation of NMDARs [2,4,6,7].
Figure 3. Analysis of the expression of NMDAR subunits in GABAergic and glutamatergic synapses at postnatal day 6–7. A,
Percentage of synapses positive for different NMDAR subunits out of all identified glutamatergic (white columns) and GABAergic synapses (black
columns). B, Linear density of labeling (gold particle/mm) for different NMDAR subunits in glutamatergic synapses (white columns), GABAergic
synapses (black columns) and extrasynaptic membranes (grey columns), measured on 100 nm thick electron microscopic sections. The extrasynaptic
density of labeling was 0.09, 0.03 and 0.02 immunogold particles/mm for GluN1, GluN2B and GluN2A subunits, respectively. C, Size (mm2) of
glutamatergic (white column) and GABAergic (black column) synapses. Data shown in A, B and C were measured from preembedding experiments.
D, Density of labeling (gold particle/mm) for GluN1 subunits in glutamatergic synapses (white column), GABAergic synapses (black column) and
extrasynaptic (E.S.) membranes (grey column, 0.03 gold particles/mm), measured from quantitative post-embedding experiments.
doi:10.1371/journal.pone.0037753.g003
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Figure 4. Quantitative post-embedding immunogold labeling reveals NMDAR expression levels in GABAergic and glutamatergic
synapses at postnatal day 6–7. The same synapses were reacted with antibodies against different epitopes on adjacent ultrathin sections using
the mirror technique. 10 nm immunogold particles label presynaptic glutamatergic (vGluT1 positive) terminals in A1 and B1. Intensified immunogold
particles label presynaptic GABAergic (GAD65/67 positive) terminals in C1 and D1. 10 nm immunogold particles (arrows) label GluN1 subunits in A2-3,
NMDA Receptors in Developing GABAergic Synapses
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The importance of NMDAR function during development is
confirmed by vast amounts of experimental data. The lack of
GluN1 subunit is lethal, mice without GluN2B subunit die within
1 day from birth [34–36], the blockade of NMDARs disrupts SSA-
s both in the hippocampus and neocortex [6,7], while its blockade
only on postnatal day 7 reduces the number of neurons, mRNA
levels of synaptophysin, and leads to behavioral dysfunction in the
adult animals [12]. In addition, inhibition of NMDARs during
development alters protein translation, disrupts synapse formation
and hippocampus-dependent learning [11], for review see Bois
et al, 2007 [37].
NMDARs are voltage and ligand gated ion channels, in
addition to binding glutamate, they need coincident depolarization
in order to get rid of the Mg2+-block, and take up the open
conformation. In the adult brain, activation of AMPA receptors
provides this depolarization. However, the first glutamatergic
synapses are ‘‘silent’’, expressing only NMDARs, and incorporate
AMPARs only later [15,19,38,39]. During development, synapto-
genesis is sequential, as GABAergic synapses are the first to be
established, followed by glutamatergic ones [21,22]. GABA, the
main inhibitory neurotransmitter in the adult brain, exerts
depolarizing actions during development, and is involved in the
generation of SSA-s (reviewed in [18]). The depolarizing nature of
GABAergic transmission is a universal feature of the developing
CNS, and has also been shown in the human brain [40,41]. The
depolarizing effect of GABA is essential for the establishment of
proper neuronal morphology and synapse formation in vivo
[5,20,42] and provides the depolarization required for the removal
of the Mg2+-block from NMDARs to drive SSA-s [4,5,43].
According to current views, the GABAAR-driven depolarization
spreads to nearby glutamatergic synapses [4,5], and leads to the
activation of NMDARs and subsequent ‘‘AMPAficaton’’ [13,15]
of these synapses. However, our results suggest that NMDAR
activation takes place first within the GABAergic synapses
themselves.
NMDA and GABAA Receptor Cooperation within
GABAergic Synapses during Early Development –
Involvement in the Generation of Spontaneous
Synchronous Activity
A large amount of data has been gathered during the past years
on the developmental expression of NMDARs. GluN1 subunit
mRNA and protein are present from early development, however
the GluN2B/GluN2A ratio decreases during this period in rodent
[24,25,28] and human brain [44]. The presence of GluN1 and
GluN2 subunits in synapses was shown during development [19],
furthermore GluN1 subunits are suggested to be expressed
extrasynaptically during this period [27]. In spite of the growing
mass of data, the exact subcellular distribution of NMDARs
during development is still unknown and more importantly, the
type of terminals that establish NMDAR containing synapses was
not yet identified. We performed different combinations of
labeling experiments, and found that GluN1, GluN2B and
GluN2A subunits of the NMDARs were expressed exclusively
postsynaptically in identified glutamatergic and GABAergic
synapses. These data corroborate our previous study in which
we showed the presence of NMDARs in GABAergic synapses of
the adult hippocampus [23]. However, during development, these
NMDARs have a different role, and are in a perfect position in the
GABAergic synapses to respond to postsynaptic depolarization
evoked by GABA. Our quantitative postembedding immunogold
data demonstrated that NMDARs are enriched in glutamatergic
and GABAergic synapses, while the former had only about 60%
more NMDARs per synapse. This difference changes dramatically
in the adult brain, where glutamatergic synapses contain 5 times
more NMDARs than GABAergic ones [23]. The relatively higher
level of NMDARs in GABAergic synapses during the first
postnatal week suggests a fundamental role of these receptors in
this location.
Our result that GABAA- and NMDA-receptors are co-
expressed in GABAergic synapses can provide the anatomical
basis for a new model of the initial generation of spontaneous
synchronous activity during early development. We propose that
the local depolarization in GABAergic synapses removes the
Mg2+-block from postsynaptic NMDARs located in the very same
synapses, and the subsequent Ca2+-influx, together with outward
chloride currents initiates a strong local depolarization that
spreads to nearby glutamatergic synapses, allowing the activation
of those NMDARs as well (Fig.5). This mechanism would employ
a homosynaptic cooperation between GABAA- and NMDA-
receptors, and a subsequent heterosynaptic activation, instead of
an exclusively heterosynaptic effect proposed before [4,5].
Furthermore, Ca2+-influx via NMDARs in GABAergic synapses
may also participate in synaptic plasticity mechanisms, and can
contribute to the activity-dependent stabilization of these synapses
during development.
B2, C2, D2. Note that the postembedding immunoreaction is on the surface of the sections, therefore, the position of gold particles can be on either
side of the postsynaptic membrane, even if the labeled epitope is purely postsynaptic. Images from adjacent sections of the same synapses are
displayed in A1-3, in B1-2, in C1-2 and in D1-2. Scale bar is 200 nm for all images.
doi:10.1371/journal.pone.0037753.g004
Figure 5. Schematic drawing shows the proposed mechanism
for GABAAR and NMDAR cooperation during early postnatal
development. Our results that GABAA and NMDA receptors are co-
expressed in GABAergic synapses can provide the anatomical basis for
a new model of the generation of SSAs during the postnatal period. The
GABAAR mediated current leads to postsynaptic depolarization in the
GABAergic synapse that allows activation of NMDARs located in
the same synapse. This homosynaptic receptor activation in GABAergic
synapses causes strong local depolarization that leads to a subsequent
heterosynaptic activation of NMDARs in otherwise silent (AMPA
receptor-lacking) glutamatergic synapses. The schematic drawing
illustrates the position of GABAAR and NMDAR at synapses, where
their presence has already been proven by others or in our current
study.
doi:10.1371/journal.pone.0037753.g005
NMDA Receptors in Developing GABAergic Synapses
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Possible Anchoring Mechanisms and the Source of
Ligands for NMDARs in GABAergic Synapses
NMDARs are anchored to the postsynaptic density via PDZ-
domain containing proteins in glutamatergic synapses. There are
at least two PDZ-domain containing proteins present in the
postsynaptic densities of GABAergic synapses, which could serve
as anchoring sites for NMDARs. Synaptic scaffolding molecule
(SSCAM) was found in GABAergic synapses [45], and was also
shown to interact with NMDARs [46,47]. Another PDZ-domain
containing protein found in GABAergic synapses during de-
velopment is glutamate receptor interacting protein 1 (GRIP1)
[48–52]. Knocking out either of these two proteins is lethal,
suggesting their important role from early development [53,54].
Glutamate and aspartate are the most potent endogenous
ligands of NMDARs. A possible source of NMDAR activation in
GABAergic synapses could be glutamate spillover from neighbor-
ing glutamatergic synapses. However, there are multiple other
possible sources, some of which being probably in a more
favorable location to activate these NMDARs. Glutamate release
from GABAergic terminals has been shown in the adult brain from
vesicular glutamate transporter 3 (vGluT3) expressing vesicles
[55], and vGluT3 is also expressed in the hippocampus during
development [56]. Vesicular co-release of aspartate from GA-
BAergic terminals has also been described in the hippocampus
[57]. These results suggest that endogenous ligands released from
GABAergic terminals could activate NMDARs in the same
synapses. Other sources of ligands are also possible. The release
of different neurotransmitters from axonal growth cones is well
known [58,59], and the release of glutamate from growth cones or
astrocytes has also been described [60–64]. Furthermore, gluta-
mate released from astrocytes can control synaptic strength [65],
and influence GABAergic synaptic transmission [66]. Aguado and
co-workers also showed that spontaneous Ca2+-transients could be
observed in the astrocytic network during development, which is
synchronous with neuronal SSA-s [67]. Thus, astrocyte-derived
glutamate can also play a role in activating NMDARs in
GABAergic synapses.
The expression levels of glial glutamate transporters were shown
to be relatively low during postnatal development [68]. The level
of extracellular glutamate using microdialysis probe was found to
be between 0.4–1 mM in adult animals [69–71], and develop-
mental levels were claimed to be similar [68]. Since glutamate
activates NMDARs efficiently (EC50: 0.4–1.8 mM) [72], the
ambient extracellular glutamate – derived from either of the
above mentioned sources – should also be sufficient to activate
NMDARs.
In our previous study, we showed that the retrograde nitric
oxide signaling pathway could be activated via NMDARs in
GABAergic synapses of the adult hippocampus [73,23]. We also
showed the presence of the nitric oxide signaling pathway in
glutamatergic and GABAergic synapses of the developing brain,
and the ability of this pathway to modulate synaptic transmission
and to control SSAs during development [74]. Therefore, the
enrichment of NMDARs in GABAergic synapses may not only be
essential for the efficient induction of SSAs during development,
but it is ideal for the local activation of this Ca2+-dependent
retrograde nitric oxide-pathway.
Materials and Methods
Ethics Statement
All experiments were performed in accordance with the
Institutional Ethical Codex and the Hungarian Act of Animal
Care and Experimentation guidelines, which are in concert with
the European Communities Council Directive of November 24,
1986 (86/609/EEC). The Animal Care and Experimentation
Committee of the Institute of Experimental Medicine of Hungar-
ian Academy of Sciences and the Animal Health and Food
Control Station, Budapest, have specifically approved the exper-
imental design under the number of 2302/003/FO˝V/2006.
Animals and Tissue Preparation
14 six- or seven-day-old male C57BL/6 mice were anesthetized
with inhalation of isoflurane, followed by an intraperitoneal
injection of 0.05–0.1 ml of an anesthetic mixture (containing
8.3 mg/ml ketamine, 1.7 mg/ml xylazin-hydrochloride, 0.8 mg/
ml promethazinium-chloride). Animals were perfused transcar-
dially with 0.9% NaCl solution for 1 minute, followed by a fixative
for 40 minutes and finally 0.1 M PB for 10 minutes. The fixative
contained 4% freshly depolymerized paraformaldehyde in 0.1 M
phosphate buffer (PB) pH 7.4 for all experiments, except for the
pre-embedding vGluT1-immunoperoxidase and GAD-immuno-
peroxidase single immunoreactions. The animals in the latter two
reactions were perfused with a fixative containing 4% para-
formaldehyde plus 0.25% glutar-aldehyde in PB. After perfusion,
brains were removed and were not postfixed. Blocks containing
the dorsal hippocampi were dissected and coronal sections were
prepared on a vibratome (VT1200S, Leica, Germany) at 40–
60 mm thickness for immunofluorescent experiments, 70–80 mm
thickness for pre-embedding electron microscopy reactions and
300 mm thickness for freeze-substitution and low-temperature
embedding. In all preembedding experiments, where we labeled
NMDARs, the tissue was treated with pepsin for epitope retrieval
– as described below. In other reactions, pepsin treatment was not
performed.
Primary Antibodies
For a summary of the antibodies used, see Table 1. We used
a mouse monoclonal antibody raised against the amino acid
residues 4-101 of GAD67 to label GABAergic terminals (Milli-
pore, MAB5406, clone 1G10.2). The specificity of this antibody
has been tested before [75]. To identify GABAergic terminals in
the immunofluorescent and post-embedding experiments we used
the GAD65/67 antibody No. 1440 raised in sheep [76,77]. This
antibody labels specifically the 65 and the 67 kD molecular weight
isoforms of GAD [78]. To label glutamatergic terminals selective-
ly, we used two antibodies. The first was a polyclonal guinea-pig
antibody, raised against a synthetic peptide from rat vGluT1,
which peptide does not overlap with the sequence of vGluT2;
(Millipore, AB5905). The specificity of this antibody has also been
described, and it gave identical staining with a well-characterized
rabbit anti- vGluT1 antibody [79]. The other antibody for labeling
glutamatergic terminals was a rabbit anti-vGluT1 antibody (Cat.
No.: 135 303, aa 456–560, Synaptic Systems), which has also been
characterized, and gave identical labeling with AB5905 [80].
For the labeling of synapses, we used a mouse monoclonal
antibody against Bassoon, a presynaptic cytoskeletal protein [81],
which is present both in GABAergic and glutamatergic synapses
[82]. This monoclonal antibody (Abcam, clone: SAP7F) was tested
using transgenic knock-out (KO) mice lacking the Bassoon protein,
and no labeling could be observed in the KO animal [83]. The
specificity of the rabbit antibodies against the C-terminus of the
NMDAR subunits GluN1, GluN2A and GluN2B had been well-
characterized using immunoblot, antigen peptides and null mutant
mice or conditioned knockout mice in both pre- and postembed-
ding experiments [29,84–86]. In the immunofluorescent experi-
ments and double immunogold-immunoperoxidase reactions we
used the same preembedding digestion protocol, as was used in the
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experiments for testing the specificity of the antibodies [86]. In
addition, immunogold labeling against the different GluN1,
GluN2A and GluN2B subunits displayed the same distribution
in the tissue. We also used a mouse monoclonal antibody against
the extracellular loop of the GluN1 subunit (Millipore, MAB363,
clone: 54.1). The specificity of this antibody was proved using
cortical pyramidal cell restricted GluN1 knockout animals [87].
To label GABAA-receptors, we used a guinea pig antibody raised
against the beta3 subunit (produced and characterized in the
laboratory of Ryuichi Shigemoto, Okazaki, Japan) [88], or a rabbit
polyclonal antibody raised against the gamma2 subunit (Synap-
ticSystems, raised against amino acids 39–67, cat. nr.: 224 003).
The specificity of the latter antibody was confirmed by viral
mediated focal deletion of GABAAR gamma2 subunit in mice
(personal communication by La´szlo´ Acsa´dy, Budapest, Hungary).
We extensively tested the possible cross-reactivity of the
fluorescent secondary and gold conjugated secondary antibodies
used in multiple labeling experiments. No cross-reactivity was
found in any of the cases. Selective labeling, resembling that
obtained with the specific antibodies, could not be detected if
primary antibodies were omitted. In the post-embedding control
reactions unspecific binding of gold conjugated secondary
antibodies was totally absent without primary antibodies. In the
pre-embedding control reactions the 1.4 nm gold conjugated goat
anti-rabbit Fab-fragment (NanoProbes) was tested without prima-
ry antibodies. This secondary antibody gave a linear density of
only 0.006 gold particles/mm, when applied at 1:100 dilution. This
is two orders of magnitude smaller, than the lowest detected
synaptic immunogold density.
Immunofluorescent Labeling and Confocal Laser-
scanning Microscopy
Before the immunofluorescent stainings, the sections were
washed in PB. For synaptic detection of NMDARs, pre-
treatment with pepsin is essential [86], thus sections were
incubated in 0.2 M HCl solution containing 1 mg/ml pepsin
(Dako) at 37Cu for 2–5 minutes in all immunofluorescent
experiments. This was followed by washes in PB and tris-
buffered saline (TBS) and blocking for 1 hour in 1% human
serum albumin (HSA) (Sigma) dissolved in TBS. After this,
sections were incubated in mixtures of primary antibodies
overnight at room temperature. In the quadruple-labeling
experiments the primary antibodies were the guinea-pig anti-
vGluT1 (1:8000), the sheep anti-GAD65/67 (1:10000), the
mouse anti-Bassoon (1:8000) and the rabbit anti-GluN1 (1:400)
antibodies, diluted in TBS. In the experiments for the direct
colocalization of NMDARs and GABAARs a triple- and
a double-labeling reaction was performed. In the triple reaction,
a mixture of the following primary antibodies was used: the
mouse anti-Bassoon (1:5000), the rabbit anti-GluN1 (1:500) and
the guinea pig anti-beta3 subunit of GABAA receptor (1:800). In
the double reaction we used the mouse anti-GluN1 (1:500) and
the rabbit anti-gamma2 subunit of GABAA-receptor (1:4000).
After incubation in primary antibody mixtures, sections of the
quadruple reaction were washed in TBS and incubated for 4
Table 1. Antibodies used in the study.
Primary antibodies
Raised in Raised against Protein conc. Fluorescent Preemb. Postemb. Source Characterized
mouse GAD67 1000 mg/mL – 1:3000 – Millipore, MAB5406, clone: 1G10.2 Ref.: 75
sheep GAD65/67 not available 1:10000 – 1:50 Oertel et al., Ab. No. 1440 Ref.: 76–78
guinea-pig vGluT1 not available 1:8000 1:10000 – Millipore, AB5905 Ref.: 79
rabbit vGluT1 1000 mg/mL – – 1:500 SynapticSystems, Cat. No.: 135 303 Ref.: 80
mouse Bassoon 1000 mg/mL 1:5000–1:8000 – – Abcam, ab82958, clone: SAP7F407 Ref.: 81–83
rabbit GluN1 720 mg/mL 1:500 1:400 1:30 Prof. Masahiko Watanabe, C2-casette Ref.: 29, 84, 86
rabbit GluN2A 542 mg/mL – 1:400 – Prof. Masahiko Watanabe, C-terminal Ref.: 29, 84, 86
rabbit GluN2B 264 mg/mL – 1:400 – Prof. Masahiko Watanabe, C-terminal Ref.: 25, 84–86
mouse GluN1 1000 mg/mL 1:500 – – Millipore, MAB363, clone: 54.1 Ref.: 87
guinea-pig GABAAR b3 serum 1:800 – – Prof. Ryuichi Shigemoto, C-terminal Ref.: 88
rabbit GABAAR c2 1000 mg/mL 1:4000 – – SynapticSystems, cat. no.: 224 003 See text.
Secondary antibodies
Conjugated with Raised in Raised against Dilution Source Molecule
DyLight 405 donkey guinea-pig 1:400 Invitrogen whole IgG
Alexa 488 donkey rabbit 1:400 Invitrogen whole IgG
Cy3 donkey mouse 1:1000 Invitrogen whole IgG
Alexa 647– streptavidin (not antibody) 1:1000 Invitrogen streptavidin
biotin donkey sheep 1:1000 Jackson Laboratories whole IgG
biotin donkey guinea-pig 1:200 Vector Laboratories whole IgG
biotin donkey mouse 1:200 Vector Laboratories whole IgG
1.4 nm gold particle goat rabbit 1:200 Nanoprobes Fab-fragment
10 nm gold particle goat rabbit 1:100 British Biocell International whole IgG
6 nm gold particle donkey sheep 1:100 Aurion whole IgG
doi:10.1371/journal.pone.0037753.t001
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hours in biotinylated donkey anti-sheep antibody (1:1000,
Jackson Laboratories) diluted in TBS. After subsequent washes
in TBS, sections were incubated for 4 h in the mixture of the
following secondary antibodies: DyLight 405 conjugated don-
key-anti-guinea-pig (1:400, Invitrogen), Alexa488 conjugated
donkey-anti-rabbit (1:400, Invitrogen), Cy3 conjugated donkey-
anti-mouse (1:1000, Invitrogen), and Alexa647 conjugated
streptavidin (1:1000, Invitrogen). In the triple reaction, the
secondary antibodies were: DyLight 405 conjugated donkey-
anti-guinea-pig (1:400), Alexa488 conjugated donkey-anti-rabbit
(1:400), Cy3 conjugated donkey-anti-mouse (1:1000), and in the
double reaction: Alexa488 conjugated donkey-anti-rabbit
(1:400), Cy3 conjugated donkey-anti-mouse (1:1000). Secondary
antibody incubation was followed by washes in TBS, PB, and
the sections were mounted onto glass slides, coverslipped with
Aqua-Poly/Mount (Polysciences). Immunofluorescence was ana-
lyzed using a Nikon Eclipse Ti-E inverted microscope (Nikon
Instruments Europe B.V., Amsterdam, The Netherlands), with
a CFI Plan Apochromat VC 606H oil immersion objective
(numerical aperture: 1.4) and an A1R laser confocal system. We
used 405, 488, 561 and 642 nm lasers (CVI Melles Griot), and
scanning was done in line serial mode. Image stacks were
obtained with NIS-Elements AR software, and deconvolved
using Huygens Professional software (www.svi.nl).
Pre-embedding Immunoelectron-microscopy
We performed single immunoperoxidase experiments to
measure the sizes of glutamatergic and GABAergic synapses.
Only for these reactions, we used strongly fixed sections (4%
paraformaldehyde plus 0.25% glutaraldehyde) and washed them
in PB and TBS. These sections were not treated with pepsin.
Next, we blocked them in 1% HSA diluted in TBS for 1 h, and
incubated them with either anti-vGluT1 (1:10000) or mouse
anti-GAD67 (1:3000) diluted in TBS for 48 hours. This was
followed by washes in TBS, and a 24 h incubation, either with
biotinylated donkey anti-guinea pig (1:200, Vector Laboratories)
or biotinylated donkey anti-mouse (1:200, Jackson Laboratories)
diluted in TBS. Next, we washed the sections in TBS, and
incubated them in Elite ABC (1:300, Vector Laboratories)
diluted in TBS. After this, sections were washed in TBS, and
tris-buffer (TB) pH 7.6. The immunoperoxidase reaction was
developed using 3,3-diaminobenzidine (DAB, Sigma-Aldrich) as
chromogen. After subsequent washes, sections were osmified
and processed for dehydration.
For combined immunogold-immunoperoxidase stainings we
used 4% paraformaldehyde fixed tissue. Sections were washed in
PB, treated with pepsin as described above, and further washed in
PB and TBS. After this, we incubated the sections in 1% HSA
diluted in TBS. Then the sections were incubated for 48 hours in
the following solutions of primary antibodies diluted in TBS: either
guinea-pig anti-vGluT1 (1:10000) or mouse anti-GAD67 (1:3000)
was mixed with rabbit anti-GluN1 (1:400), or rabbit anti-GluN2B
(1:400), or rabbit anti-GluN2A (1:400). After repeated washes in
TBS, sections were treated with blocking solution (Gel-BS)
containing 0.5% cold water fish skin gelatin (GE Healthcare,
Little Chalfont, UK) and 0.5% HSA in TBS for 1 h. This was
followed by 24 h incubation in the following solutions of secondary
antibodies diluted in Gel-BS: 1.4 nm gold conjugated goat anti-
rabbit Fab-fragment (1:200, NanoProbes) combined either with
biotinylated donkey anti-guinea pig (1:200, Vector Laboratories)
or biotinylated donkey anti-mouse (1:200, Jackson Laboratories).
After intensive washes in TBS and 0.1 M PB sections were treated
with 2% glutar-aldehyde in 0.1 M PB for 15 minutes to fix the
gold particles into the tissue. This was followed by further washes
in 0.1 M PB, TBS and incubation in Elite ABC (1:300, Vector
Laboratories) diluted in TBS. After this, sections were washed in
TBS, and tris-buffer (TB) pH 7.6. The immunoperoxidase re-
action was developed using 3,3-diaminobenzidine (DAB, Sigma-
Aldrich) as chromogen. After repeated washes in TBS and
enhancement conditioning solution (ECS, Aurion), gold particles
were intensified using the silver enhancement solution (SE-EM,
Aurion) for 40–60 minutes at room temperature. After subsequent
washes, sections were treated with 0.5% osmium-tetroxide in PB
for 20 minutes. Then sections were dehydrated in ascending
ethanol series and acetonitrile, and embedded in epoxy resin
(Durcupan, ACM, Fluka, Buchs, Switzerland). During dehydra-
tion sections were treated with 1% uranyl-acetate in 70% ethanol
for 20 minutes. For the electron microscopic investigations, resin
infiltrated hippocampi were placed into silicone moulds, and
cured. After polymerization, 80–100 nm thick sections were cut
using a Leica EM UC6 ultramicrotome (Nussloch, Germany), and
picked up on formvar-coated single-slot copper grids. The sections
were examined using a Hitachi H-7100 electron microscope
(Tokyo, Japan) and a side-mounted Veleta CCD camera
(Olympus Soft Imaging Solutions).
Post-embedding Immunoelectron-microscopy
For Lowicryl embedding the same procedure was used as
described previously [89–91]. Briefly, after washing in PB, the
300 mm thick sections from 4% paraformaldehyde fixed hippo-
campi were transferred into sucrose solutions in 0.1 M PB for
cryoprotection. After slamming onto gold-plated copper blocks
cooled in liquid nitrogen, low temperature dehydration, and
freeze-substitution, the sections were embedded in Lowicryl
HM20 resin (Chemische Werke Lowi). Postembedding immuno-
histochemistry was performed on 70 nm thick sections of Low-
icryl-embedded hippocampi from two mice. The sections were
picked up on formvar-coated single slot nickel grids, allowing
immunoreaction on one side of the sections. These reactions were
used to compare NMDAR expression between GABAergic and
glutamatergic synapses by colocalizing the GluN1 subunit either
with GAD65/67 or vGluT1, using the mirror technique. Long,
continuous series of sections were picked up on grids in a way, that
synapses cut in halves could be treated with different antibody
solutions on adjacent sections. Grids were incubated on drops of
blocking solution for 1 h, followed by incubation on drops of
primary antibodies overnight. The blocking solution, which was
also used for diluting the primary and secondary antibodies,
contained 2% HSA and 0.03% Triton X-100 in TBS. Three
adjacent grids were used, the first grid was reacted against the
rabbit anti-vGluT1 (1:500), the second grid was reacted against
rabbit anti-GluN1 (1:30), and the third grid was reacted against
sheep anti-GAD65/67 (1:50). This way, we could measure the
NMDAR content of identified GABAergic and glutamatergic
synapses on the very same grids. After incubation in primary
antibodies for 18 h, sections were washed in TBS and incubated
for 5 h on drops of secondary antibodies diluted in blocking
solution, which contained polyethylene-glycol (0.5 mg/ml). We
used 10 nm gold particle conjugated goat anti-rabbit (1:100;
British Biocell International), and 6 nm gold particle conjugated
donkey anti-sheep (1:100; Aurion) secondary antibodies. The
6 nm gold particles were intensified using silver enhancement
solution (SE-EM; Aurion) for 35 min at room temperature. After
several washes, sections were rinsed in ultrapure water and
contrasted with saturated aqueous uranyl acetate and lead citrate.
The sections were examined using a Hitachi H-7100 electron
microscope (Tokyo, Japan) and a side-mounted Veleta CCD
camera (Olympus Soft Imaging Solutions).
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Analysis
When data populations in this work had a Gaussian distribution
according to the Shapiro-Wilks W test, we reported parametric
statistical features (mean 6 SD), otherwise we reported non-
parametric statistical features (median, interquartile range). All
examined synapses in this work were sampled from the stratum
radiatum of the hippocampal CA1 area. The sizes of glutamater-
gic and GABAergic synapses were measured from serial sections of
fully reconstructed synapses. The length between the edges of
anatomically defined synapses was measured on subsequent
images of the sampled synapses, and the sum of the measured
lengths from each synapse was multiplied by the section thickness.
For the semi-quantitative analyses of immunogold particles for
NMDAR subunits in the pre-embedding experiments, we counted
gold particles within the defined GABAergic and glutamatergic
synapses and along the extrasynaptic membrane. Immunogold
particles were considered to be membrane or synapse-associated, if
they were not further away from the membrane than 40 nm. In
the post-embedding immunogold reactions, 40 nanometer-wide
bands were chosen on the two sides of the synaptic membrane as
an area representing membrane-associated gold particle labeling.
The reason for choosing 40 nm bands is that the epitope (the C-
terminus of the NMDAR) is located a few nanometers in-
tracellularly, the length of the primary and secondary IgG
antibody molecules are ,15 nm each, and the radius of gold
particle is 5 nm. According to our experience, gold particles may
also move a few nanometers on the surface of the section after
immunohistochemistry, which can also cause a few nanometers of
shift in receptor labeling. However, this distribution was also tested
in postembedding reactions and we found that actually the
majority of all gold particles were within two 20-nm-wide bands
from the postsynaptic membrane in both GABAergic and
glutamatergic synapses (median: 3.63 nm, interquartile range:
28.12–13.78 nm; median 7.26 nm, interquartile range 27.87–
13.49 nm, respectively). For the measurements, we used open-
source image analyzing software: ImageJ/Fiji.
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